EWTX
Edgewise Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.52B
P/E Ratio
—
EPS
$-1.66
Beta
0.25
52W High
$39.96
52W Low
$12.15
50-Day MA
$32.36
200-Day MA
$24.09
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Edgewise Therapeutics Inc
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The company is headquartered in Boulder, Colorado.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-197.45M |
| Operating Margin | 0.00% |
| Return on Equity | -38.10% |
| Return on Assets | -25.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.59 |
| Price-to-Book | 7.14 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $107.59M |
| Float | $67.12M |
| % Insiders | 0.45% |
| % Institutions | 113.97% |
Historical Volatility
HV 10-Day
36.50%
HV 20-Day
78.09%
HV 30-Day
67.74%
HV 60-Day
56.09%
HV Rank
59.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($43.67 target)
3
Strong Buy7
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026